Consistent with our results, previous studies showed that S100A9+ cell density was associated with a poor prognosis in patients with other cancers, such as clear cell renal cell carcinoma [26], invasive ductal carcinoma of the breast [24], and non-small cell lung cancer [21]. This evidence concerns the gene S100A9 and invasive ductal breast carcinoma.